$2.48
-0.205[-7.64%]
At close: Apr 24
$2.48
0[0.00%]
After Hours: 7:08PM EDT
Bio-Path Hldgs
(NASDAQ:BPTH)Bio-Path Hldgs Stock (NASDAQ:BPTH), Analyst Ratings, Price Targets, Predictions
Bio-Path Holdings Inc has a consensus price target of $29.67, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Roth MKM, Roth MKM, and HC Wainwright & Co. on April 18, 2024, March 27, 2024, and May 19, 2022. With an average price target of $29.67 between Roth MKM, Roth MKM, and HC Wainwright & Co., there's an implied 1096.24% upside for Bio-Path Holdings Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Roth MKM
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Bio-Path Hldgs
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/18/2024 | BPTH | Buy Now | Bio-Path Hldgs | $2.48 | 1512.9% | Roth MKM | Philip Shen | → $40 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | BPTH | Buy Now | Bio-Path Hldgs | $2.48 | 1512.9% | Roth MKM | Jonathan Aschoff | $12 → $40 | Maintains | Buy | Get Alert |
| 05/19/2022 | BPTH | Buy Now | Bio-Path Hldgs | $2.48 | 262.9% | HC Wainwright & Co. | Yi Chen | $240 → $180 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Bio-Path Hldgs (BPTH)?
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by Roth MKM on April 18, 2024. The analyst firm set a price target for $40.00 expecting BPTH to rise to within 12 months (a possible 1512.90% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bio-Path Hldgs (BPTH)?
The latest analyst rating for Bio-Path Hldgs (NASDAQ: BPTH) was provided by Roth MKM, and Bio-Path Hldgs reiterated their buy rating.
When was the last upgrade for Bio-Path Hldgs (BPTH)?
There is no last upgrade for Bio-Path Hldgs.
When was the last downgrade for Bio-Path Hldgs (BPTH)?
There is no last downgrade for Bio-Path Hldgs.
When is the next analyst rating going to be posted or updated for Bio-Path Hldgs (BPTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bio-Path Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bio-Path Hldgs was filed on April 18, 2024 so you should expect the next rating to be made available sometime around April 18, 2025.
Is the Analyst Rating Bio-Path Hldgs (BPTH) correct?
While ratings are subjective and will change, the latest Bio-Path Hldgs (BPTH) rating was a reiterated with a price target of $0.00 to $40.00. The current price Bio-Path Hldgs (BPTH) is trading at is $2.48, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.